Pedro Huertas
CIK 1389517 · SVP, CMO · last filed 2021-01-14
Pedro Huertas is a SVP, CMO who has filed 6 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for INZY, was dated Jan 14, 2021. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.86M
2
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Inozyme Pharma, Inc. (INZY) Delisted | SVP, CMO | — | $4.00 | — | $0 | 2 | 2021-01-14 |
| ELOX | Chief Medical Officer | 137,725 | $13.52 | $1.86M | $0 | 2 | 2018-05-18 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-14 | Inozyme Pharma, Inc. (INZY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-24 | Inozyme Pharma, Inc. (INZY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-18 | ELOX | Grant (A) | +33,000 | $0 | EDGAR |
| 2018-05-11 | ELOX | Grant (A) | +104,725 | $0 | EDGAR |
| 2018-01-22 | — | Grant (A) | — | $0 | |
| 2007-09-10 | — | Buy (P) | — | $0 |